FC Capital
Overview
FC Capital is an Australian alternative asset manager founded in 2012 with a primary focus on private debt, direct lending, and specialty real estate. The firm, headquartered in Sydney, provides capital solutions to mid-market companies in the Australasian region and offers investment funds and tailored investment solutions to wholesale and sophisticated investors. Its investment strategy targets markets not well served by traditional capital sources, including corporate capital solutions, special situations, and property.
Portfolio Companies
3
Website
fccapital.com.auInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Acesion Pharma | Sep 2023 | Series B | Co-investor |
| Wagepay | Nov 2022 | Early Funding | Co-investor |
| Vedanta Biosciences | Sep 2019 | Series C Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is FC Capital based?
FC Capital is headquartered in Sydney, New South Wales, Australia.
When was FC Capital founded?
Founding year information for FC Capital is not publicly available.
How many portfolio companies does FC Capital have?
FC Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in FC Capital's portfolio?
Portfolio companies visible on Caplight include Acesion Pharma, Wagepay, Vedanta Biosciences.
What was FC Capital's most recent investment shown here?
FC Capital's most recent investment in this portfolio sample was in Acesion Pharma in 2023.
What sectors does FC Capital focus on?
FC Capital focuses on FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does FC Capital focus on?
FC Capital typically invests at the Mid stage.
What is FC Capital's AUM?
FC Capital's assets under management are estimated between $561.0M and $561.0M.